|
Market Closed -
Hong Kong S.E.
04:08:31 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 3.330 HKD | -5.13% |
|
+4.55% | +12.88% |
| 08-31 | HighTide Therapeutics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-02 | HighTide Therapeutics, CEO Terminate Loan Contract on Bourse's Concerns | MT |
Company Valuation: HighTide Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Market Cap 1 | 6,056 | 614.3 | 1,515 |
| Change | - | -89.86% | 146.54% |
| Enterprise Value (EV) 1 | 5,336 | 201.5 | 1,139 |
| Change | - | -96.22% | 464.94% |
| P/E | -3.25x | -1.41x | -5.19x |
| PBR | 8.62x | 1.45x | 4.93x |
| PEG | 0.2x | 0x | 0.1x |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -11.9x | -0.45x | -5.13x |
| EV / EBIT | -11.9x | -0.45x | -5.09x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -3.617 | -0.8445 | -0.5106 |
| Distribution rate | - | - | - |
| Net sales | - | - | - |
| EBITDA 1 | -447.7 | -443.7 | -222.2 |
| EBIT 1 | -448.2 | -444.8 | -223.6 |
| Net income 1 | -939.3 | -381.8 | -245 |
| Net Debt 1 | -719.9 | -412.8 | -376 |
| Reference price 2 | 11.764 | 1.193 | 2.651 |
| Nbr of stocks (in thousands) | 514,771 | 514,771 | 571,326 |
| Announcement Date | 4/26/24 | 4/23/25 | 4/29/26 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 256M | |
| 21.81x | 7.74x | 15.55x | 1.36% | 74.18B | |
| 30.94x | 8.91x | 27.77x | 0.04% | 59.55B | |
| -72.24x | 13.96x | -67.31x | -.--% | 25.84B | |
| -15.16x | 5.72x | -7.19x | -.--% | 24.73B | |
| 28.65x | 5.38x | 17.91x | -.--% | 20.87B | |
| 44.32x | 16.25x | 32.97x | 0.34% | 15.32B | |
| 17.52x | 5.22x | 12.18x | -.--% | 14.06B | |
| -14.32x | 3225.89x | -16.49x | -.--% | 13.12B | |
| -81.25x | 7.42x | -61.47x | -.--% | 11.85B | |
| Average | -4.41x | 366.28x | -5.12x | 0.19% | 25.98B | |
| Weighted average by Cap. | 6.13x | 171.32x | 3.83x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2511 Stock
- Valuation HighTide Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
